back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-25 14:05 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$715,000
+125,000 vol $5.72 each |
744,952 | |
| Filed 2024-04-25 14:05 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$715,000
+125,000 vol $5.72 each |
619,952 | |
| Filed 2024-04-25 14:04 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$901,809
+157,659 vol $5.72 each |
494,952 | |
| Filed 2024-04-16 18:19 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
||
| Filed 2024-04-16 18:19 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
||
| Filed 2024-04-16 18:18 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$894,854
+156,992 vol $5.70 each |
||
| Filed 2024-04-16 18:21 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$308,626
+54,145 vol $5.70 each |
95,923 | |
| Filed 2024-04-16 18:19 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
744,285 | |
| Filed 2024-04-16 18:19 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
619,285 | |
| Filed 2024-04-16 18:18 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$894,854
+156,992 vol $5.70 each |
494,285 | |
| Filed 2024-04-05 16:19 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$53,386
+10,073 vol $5.30 each |
152,212 | |
| Filed 2024-04-05 16:18 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-81,252.65
-14,381 vol $5.65 each |
41,778 | |
| Filed 2024-04-05 16:16 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-40,623.50
-7,190 vol $5.65 each |
20,889 | |
| Filed 2024-03-19 20:09 Tx date 2024-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,426
+2,156 vol $5.30 each |
142,139 | |
| Filed 2024-01-13 16:00 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$42,800
+40,000 vol $1.07 each |
95,334 | |
| Filed 2024-01-13 15:59 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-42,800
-40,000 vol $1.07 each |
1,666 | |
| Filed 2023-12-19 10:00 Tx date 2023-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$13,332
+2,564 vol $5.20 each |
139,983 | |
| Filed 2023-11-18 15:17 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,733
+1,667 vol $1.04 each |
55,334 | |
| Filed 2023-11-18 15:17 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,733.68
-1,667 vol $1.04 each |
41,666 | |
| Filed 2023-09-19 11:19 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,739
+2,656 vol $4.42 each |
137,419 | |
| Filed 2023-09-15 18:18 Tx date 2023-09-12 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
20,000 | |
| Filed 2023-06-19 14:55 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,742
+2,590 vol $4.92 each |
134,763 | |
| Filed 2023-06-19 13:28 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,737
+2,589 vol $4.92 each |
134,762 | |
| Filed 2023-06-19 13:28 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,737
+2,589 vol $4.92 each |
||
| Filed 2023-04-02 23:39 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$103,469
+23,304 vol $4.44 each |
56,159 | |
| Filed 2023-04-02 23:32 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$51,734
+11,652 vol $4.44 each |
28,079 | |
| Filed 2023-04-02 23:28 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$166,655
+37,535 vol $4.44 each |
337,293 | |
| Filed 2023-03-21 21:36 Tx date 2023-03-17 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-970,000
-125,000 vol $7.76 each |
299,758 | |
| Filed 2023-03-19 22:55 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,664
+2,116 vol $5.04 each |
132,173 | |
| Filed 2022-12-23 15:47 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,526
+288 vol $5.30 each |
130,057 | |
| Filed 2022-12-23 15:46 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,365
+1,952 vol $5.31 each |
129,769 | |
| Filed 2022-12-23 13:17 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,894
+2,240 vol $5.31 each |
130,057 | |
| Filed 2022-12-23 13:17 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,894
+2,240 vol $5.31 each |
||
| Filed 2022-12-01 22:14 Tx date 2022-11-28 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$24,960
+52,000 vol $0.48 each |
53,667 | |
| Filed 2022-12-01 22:13 Tx date 2022-11-28 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-24,960
-52,000 vol $0.48 each |
43,333 | |
| Filed 2022-11-19 12:49 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$800.16
+1,667 vol $0.48 each |
1,667 | |
| Filed 2022-11-19 12:48 Tx date 2018-03-19 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-11-19 12:48 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-800.16
-1,667 vol $0.48 each |
95,333 | |
| Filed 2022-11-19 12:45 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,000 vol |
5,000 | |
| Filed 2022-11-19 12:44 Tx date 2018-03-19 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-07 11:18 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,674
+1,896 vol $5.63 each |
127,817 | |
| Filed 2022-09-21 16:25 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$18,950
+3,366 vol $5.63 each |
||
| Filed 2022-09-21 16:25 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$18,950
+3,366 vol $5.63 each |
129,287 | |
| Filed 2022-08-16 15:53 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
528,231 | |
| Filed 2021-12-10 14:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
||
| Filed 2021-12-10 13:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
||
| Filed 2021-05-20 12:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2021-05-20 11:16 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2022-06-17 21:19 Tx date 2022-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,661
+2,234 vol $5.22 each |
125,921 | |
| Filed 2022-03-30 16:52 Tx date 2022-03-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-1,181,250
-135,000 vol $8.75 each |
424,758 | |
| Filed 2022-03-29 11:14 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$48,124
+9,237 vol $5.21 each |
16,427 | |
| Filed 2022-03-29 11:13 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$96,249
+18,474 vol $5.21 each |
32,855 | |
| Filed 2022-03-29 11:12 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$164,255
+31,527 vol $5.21 each |
559,758 | |
| Filed 2022-03-28 16:43 Tx date 2022-03-22 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,282
+1,700 vol $5.46 each |
123,687 | |
| Filed 2021-12-17 18:21 Tx date 2021-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,278
+1,969 vol $5.22 each |
121,987 | |
| Filed 2021-12-10 14:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
528,231 | |
| Filed 2021-12-10 13:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
528,231 | |
| Filed 2021-12-10 13:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
||
| Filed 2021-05-20 12:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2021-05-20 12:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2021-05-20 11:16 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2021-05-20 11:16 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2021-11-19 20:22 Tx date 2021-11-15 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+5,000 vol |
97,000 | |
| Filed 2021-09-17 17:43 Tx date 2021-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,535
+1,984 vol $5.31 each |
120,018 | |
| Filed 2021-06-18 19:49 Tx date 2021-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,795
+1,669 vol $5.27 each |
118,034 | |
| Filed 2021-05-24 15:27 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$81,252
+14,381 vol $5.65 each |
14,381 | |
| Filed 2021-05-24 15:25 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$40,623
+7,190 vol $5.65 each |
7,190 | |
| Filed 2021-05-20 12:57 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
||
| Filed 2021-05-20 12:54 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
||
| Filed 2021-05-20 11:19 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
||
| Filed 2021-05-20 11:18 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
||
| Filed 2021-05-20 13:06 Tx date 2014-08-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
85,000 | |
| Filed 2021-05-20 12:57 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
14,381 | |
| Filed 2021-05-20 12:56 Tx date 2014-08-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 12:54 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
7,190 | |
| Filed 2021-05-20 12:53 Tx date 2014-08-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 12:52 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
528,238 | |
| Filed 2021-05-20 11:19 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
14,381 | |
| Filed 2021-05-20 11:19 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
||
| Filed 2021-05-20 11:18 Tx date 2014-08-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:18 Tx date 2014-08-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:18 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
||
| Filed 2021-05-20 11:18 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
7,190 | |
| Filed 2021-05-20 11:17 Tx date 2014-08-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:17 Tx date 2014-08-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:16 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2021-05-20 11:16 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
528,238 | |
| Filed 2021-05-20 11:15 Tx date 2014-08-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
85,000 | |
| Filed 2021-05-20 11:15 Tx date 2014-08-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
||
| Filed 2014-08-27 18:03 Tx date 2014-08-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
||
| Filed 2014-08-27 18:03 Tx date 2014-08-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,000 vol |
||
| Filed 2021-04-06 08:42 Tx date 2021-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,712
+1,669 vol $5.22 each |
116,365 | |
| Filed 2021-01-15 18:41 Tx date 2021-01-11 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+40,000 vol |
92,000 | |
| Filed 2020-12-21 18:55 Tx date 2020-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,467
+1,409 vol $5.30 each |
114,696 | |
| Filed 2020-12-17 18:15 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
37 - Stock split or consolidation
|
-468,000 vol |
52,000 | |
| Filed 2020-09-28 16:52 Tx date 2020-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,709
+1,442 vol $6.04 each |
113,287 | |
| Filed 2020-07-03 16:22 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+84,288 vol |
503,298 | |
| Filed 2020-06-19 10:24 Tx date 2020-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,462
+1,054 vol $7.08 each |
111,845 | |
| Filed 2020-03-16 11:53 Tx date 2020-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,679
+1,437 vol $6.04 each |
110,791 | |
| Filed 2019-12-18 11:12 Tx date 2019-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,444
+977 vol $7.62 each |
109,354 | |
| Filed 2019-11-28 13:12 Tx date 2019-11-28 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+160,000 vol |
520,000 | |
| Filed 2019-09-18 11:37 Tx date 2019-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,675
+1,118 vol $7.76 each |
108,377 | |
| Filed 2019-07-24 15:49 Tx date 2019-07-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,660
+1,008 vol $7.60 each |
107,259 | |
| Filed 2019-04-24 16:28 Tx date 2019-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+173 vol |
106,251 | |
| Filed 2019-04-24 16:27 Tx date 2019-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,300
+839 vol $7.51 each |
106,078 | |
| Filed 2019-01-25 Tx date 2019-01-03 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,401
+640 vol $8.44 each |
||
| Filed 2019-01-25 Tx date 2018-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+153 vol |
105,239 | |
| Filed 2019-01-25 Tx date 2018-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,401
+640 vol $8.44 each |
105,086 | |
| Filed 2019-01-25 Tx date 2019-01-03 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+153 vol |
||
| Filed 2018-10-18 Tx date 2018-09-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,301
+762 vol $8.27 each |
104,336 | |
| Filed 2018-10-18 Tx date 2018-09-25 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+110 vol |
104,446 | |
| Filed 2018-10-05 Tx date 2018-03-19 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-05 Tx date 2018-10-03 |
$ATE
Antibe Therapeutics Inc. |
Khouri, Amal
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
97 - Other
|
+360,000 vol |
360,000 | |
| Filed 2018-08-14 Tx date 2018-06-26 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,405
+674 vol $8.02 each |
103,460 | |
| Filed 2018-08-14 Tx date 2018-06-26 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+114 vol |
103,574 | |
| Filed 2018-05-01 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,176
+774 vol $7.98 each |
102,683 | |
| Filed 2018-05-01 Tx date 2018-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+103 vol |
102,786 | |
| Filed 2018-02-14 Tx date 2017-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+122 vol |
101,909 | |
| Filed 2018-02-14 Tx date 2017-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,294
+693 vol $7.64 each |
101,787 | |
| Filed 2017-10-06 Tx date 2017-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+103 vol |
101,094 | |
| Filed 2017-10-06 Tx date 2017-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,182
+709 vol $8.72 each |
100,991 | |
| Filed 2017-10-06 Tx date 2017-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+110 vol |
100,282 | |
| Filed 2017-10-06 Tx date 2017-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,163
+627 vol $9.83 each |
100,172 | |
| Filed 2017-03-31 Tx date 2017-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,185
+500 vol $10.37 each |
99,457 | |
| Filed 2017-03-31 Tx date 2017-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+88 vol |
99,545 | |
| Filed 2017-03-28 Tx date 2017-03-21 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+74,010 vol |
419,010 | |
| Filed 2016-12-23 Tx date 2016-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,194
+521 vol $9.97 each |
93,957 | |
| Filed 2016-12-22 Tx date 2016-12-22 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$50,000
+5,000 vol $10.00 each |
98,436 | |
| Filed 2016-09-26 Tx date 2016-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,636
+404 vol $9.00 each |
93,436 | |
| Filed 2016-06-20 Tx date 2016-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,638
+425 vol $8.56 each |
93,032 | |
| Filed 2016-06-03 Tx date 2016-06-02 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+12,500 vol $8.00 each |
92,607 | |
| Filed 2016-03-25 Tx date 2016-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,109
+414 vol $7.51 each |
80,107 | |
| Filed 2015-12-18 Tx date 2015-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,635
+486 vol $7.48 each |
79,693 | |
| Filed 2015-12-18 Tx date 2015-12-16 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
345,000 | |
| Filed 2015-09-23 Tx date 2015-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,118
+413 vol $7.55 each |
79,207 | |
| Filed 2015-06-18 Tx date 2015-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,111
+442 vol $7.04 each |
78,794 |